Contract price indeed, but what is it going to be?
Lets be real here....I can't imagine that Ganfeng is financing some $250million capex for free, just to be able to buy at market price Spodumene from us right?
A likely and desired pricing mechanism would be if price would be set al prevailing quarterly market contract trend, less amortised $250million initial capex, for the duration of the mine life.....even accounting for some interest repayments.
I can't see Ganfeng participation in opex costs during production, it wont make sense in accounting terms, but I am trying to understand where it fits the 50% participation of Ganfeng in the project....?
We know Goulamina has a capex payback of 1 year at Spod6% price under $1000/t, so in reality Ganfeng capex financing can be paied off in few months.
Is also understandable that Ganfeng will want to get a slice of the cake above repayments of its financing, but if that is the case, how much?
I suppose all will be revealed when times come.
- Forums
- ASX - By Stock
- General Discussion
Contract price indeed, but what is it going to be?Lets be real...
Featured News
Add LLL (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $605.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LLL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online